PRESS RELEASE published on 10/07/2024 at 13:18, 1 year 10 months ago ElringKlinger hones its corporate profile and disposes of two Group companies ElringKlinger hones corporate profile, sells two Group companies to Certina Group as part of strategic decision to focus on thermal and acoustic shielding products Strategic Decision Divestment ElringKlinger Certina Group Thermal Shielding
BRIEF published on 10/07/2024 at 12:52, 1 year 10 months ago ElringKlinger AG Faces Non-Cash Losses Due to Sale of Group Companies Automotive Industry Impairment Losses ElringKlinger AG 2024 Financial Guidance Group Sale
BRIEF published on 10/07/2024 at 12:52, 1 year 10 months ago ElringKlinger AG fait face à des pertes non monétaires en raison de la vente de sociétés du groupe Industrie Automobile Pertes De Valeur Elring Klinger AG Vente Groupée Orientations Financières Pour 2024
PRESS RELEASE published on 10/07/2024 at 12:47, 1 year 10 months ago EQS-Adhoc: ElringKlinger AG: Non-cash impairment losses relating to the sale of two Group companies and adjustment to the annual guidance ElringKlinger AG announces non-cash impairment losses from sale of two Group companies and adjusts annual guidance amidst industry transformations Automotive Industry Impairment Losses ElringKlinger AG Annual Guidance Certina Group
BRIEF published on 08/07/2024 at 07:44, 2 years ago ElringKlinger Records Solid Second-Quarter Performance in 2024 EBITDA Financial Performance Revenue Automotive Market SHAPE30 Strategy
BRIEF published on 08/07/2024 at 07:44, 2 years ago ElringKlinger enregistre une solide performance au deuxième trimestre 2024 Performance Financière Marché Automobile BAIIA Revenu Stratégie SHAPE30
PRESS RELEASE published on 08/07/2024 at 07:39, 2 years ago ElringKlinger records solid second-quarter performance in 2024 ElringKlinger reports solid second-quarter performance in 2024 with EUR 445.0 million revenue, 5.0% adjusted EBIT margin, and progress on SHAPE30 transformation strategy Revenue 2024 ElringKlinger SHAPE30 Second-quarter Performance
BRIEF published on 06/25/2024 at 11:10, 2 years 1 month ago ElringKlinger to Open New Battery Center in the USA South Carolina E-mobility ElringKlinger Battery Center SHAPE30
BRIEF published on 06/25/2024 at 11:10, 2 years 1 month ago ElringKlinger va ouvrir un nouveau centre de batteries aux États-Unis E-mobilité ElringKlinger Centre De Batterie Caroline Du Sud FORME30
PRESS RELEASE published on 06/25/2024 at 11:05, 2 years 1 month ago ElringKlinger to open new Battery Center in the USA ElringKlinger AG announces the opening of a new Battery Center in the USA, focusing on manufacturing battery technology products for the American market Manufacturing E-mobility ElringKlinger AG USA Battery Center
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Galantas Gold Expands Indiana Drill Program to 12,500 Metres
Published on 08/10/2026 at 08:00, 2 hours 9 minutes ago Results of AGM and Management Update Presentation
Published on 08/07/2026 at 23:15, 2 days 10 hours ago Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 2 days 11 hours ago Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/10/2026 at 09:50, 19 minutes ago Photon Energy N.V. Bond 21/27 (ISIN: DE000A3KWKY4): Signs of a crisis are mounting. What can investors do? Invitation to video conferences (German/English)
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Rosenbauer International AG (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Original-Research: Bittium Oyj (von NuWays AG): BUY
Published on 08/10/2026 at 09:00, 1 hour 9 minutes ago Synnovis milestone: 2,000 revolutionary blood tests for NHS lung and breast cancer patients
Published on 08/10/2026 at 09:22, 46 minutes ago Number of shares and voting rights - July 2026 (In French only)
Published on 08/10/2026 at 09:22, 46 minutes ago Nombre total d'actions et droits de vote - juillet 2026
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
Published on 08/10/2026 at 07:00, 3 hours 9 minutes ago Biophytis annonce l’autorisation de l’étude clinique OBA au Brésil et partage les perspectives de BIO101 dans l’obésité
